亿腾医药  Eddingpharm
亿腾成立于2001年，作为中国领先的专业医药公司，我们长期以来一直致力于将全球优质的药品带入中国医疗市场，提供给病患更多的治疗及康复机会，促进中国临床专家和全球领先医学研究机构的合作和交流，为中国临床医生提供学术支持。

公司自2001年成立以来，发展至2011年底，在国内雇员已超过700名，主要从事药品的经销和推广、产品注册以及临床试验的管理等业务。

公司于2012年3月在美国成立Eddingpharm (U.S.) Company,并在洛杉矶组建了具备研发背景的产品发展团队，主要从事与全球领先的研发机构的协调和沟通，寻求将处于临床前或临床试验阶段的创新专利药物引进中国市场的机会。

公司聚焦于临床营养、抗肿瘤治疗、抗感染治疗、呼吸系统疾病治疗等领域的产品发展以及医学推广。

我们力争通过和跨国医药公司、海外专业医药公司、全球领先研发机构等合作，以专利授权引进、成立合资公司、建立战略联盟、独家经销等形式建立聚焦于上述四个主要治疗领域的产品组合。

目前亿腾已与多家跨国医药公司和海外专业医药公司建立起长期合作的关系，在上述四个治疗领域建立了富有市场竞争优势的产品组合以及产品线；同时亿腾还在积极发展与全球领先研发机构合作,授权引进创新药物的中国市场权利。

经过多年的努力，至2011年年底亿腾的市场学术推广人员发展超过600名，针对中国市场已形成一套高度整合与管理良好的市场营销系统，医学推广覆盖至全国大部分主要城市，同年12月底我们经销的产品或医学推广代表覆盖至超过2900家医院。

Eddingpharm was founded in 2001. As China’s leading pharmaceuticals marketing company, Eddingpharm has been committed to bring in high quality medicines from all over  the world to the Chinese market, to provide patients more treatment options and better opportunity of recovery.  We promote the cooperation and exchanges between Chinese clinical experts and the leading international medical research institutions. We provide academic support to Chinese clinical doctors.

Since its inception in 2001, the company has grown into an organization of more than 700 employees in China by the end of  2012. The company focuses on product sales and marketing, product registration,  and clinical trials management.

In March, 2012, Eddingpharm established Eddingpharm (U.S.) Company in USA, and set up a business development team with strong research and development background. The team is engaged in coordination and communication with the world’s leading research and development institutions and biotech companies. It is actively seeking the opportunity to introduce innovative proprietary medicines in pre-clinical or clinical development phase into the Chinese market.

The company is engaged in the product development and sales and marketing in four core therapeutic areas: clinical nutrition, oncology, antibiotics and respiratory-system.
 

We strive to create a portfolio of products focused on the above mentioned four major therapeutic areas, through strategic alliance, including exclusive distribution, product in-licensing, and joint-venture, with world’s leading pharmaceutical companies, overseas specialized pharmaceutical companies, and global leading research and development focused biotech companies.
 

Eddingpharm has established long-term cooperative relationship with a number of multinational pharmaceutical companies and overseas specialty pharmaceutical companies, and has built up a competitive product portfolio and pipeline in the four major therapeutic areas. At the same time, Eddingpharm is actively developing cooperation with the leading global biotech companies and research and development institutions to gain the regional rights of innovative medicines and to introduce them to the China market.
 

Through years effort, Eddingpharm has assembled  a team of nearlysales and marketing professionals and established a highly integrated and well-managed sales network covering most of the major cities across the country. By December 2012, our products and our sales and marketing professionals have covered more than 3000 hospitals.